Curis, Inc. (CRIS)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
Curis Shareholders Equity (Quarterly) : 4.695M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.695M |
| March 31, 2026 | 12.71M |
| December 31, 2025 | 5.462M |
| September 30, 2025 | -14.69M |
| June 30, 2025 | -13.99M |
| March 31, 2025 | -6.607M |
| December 31, 2024 | -5.998M |
| September 30, 2024 | -8.735M |
| June 30, 2024 | -0.694M |
| March 31, 2024 | 9.462M |
| December 31, 2023 | 19.67M |
| September 30, 2023 | 29.59M |
| June 30, 2023 | 26.22M |
| March 31, 2023 | 36.59M |
| December 31, 2022 | 46.55M |
| September 30, 2022 | 55.74M |
| June 30, 2022 | 62.04M |
| March 31, 2022 | 75.97M |
| December 31, 2021 | 90.71M |
| September 30, 2021 | 102.91M |
| June 30, 2021 | 112.47M |
| March 31, 2021 | 121.92M |
| December 31, 2020 | 130.67M |
| September 30, 2020 | -28.61M |
| June 30, 2020 | -30.38M |
| Date | Value |
|---|---|
| March 31, 2020 | -40.27M |
| December 31, 2019 | -33.91M |
| September 30, 2019 | -26.02M |
| June 30, 2019 | -20.27M |
| March 31, 2019 | -13.73M |
| December 31, 2018 | -4.496M |
| September 30, 2018 | 0.782M |
| June 30, 2018 | 7.11M |
| March 31, 2018 | 14.47M |
| December 31, 2017 | 23.99M |
| September 30, 2017 | 30.45M |
| June 30, 2017 | 9.228M |
| March 31, 2017 | 21.48M |
| December 31, 2016 | 29.27M |
| September 30, 2016 | 37.87M |
| June 30, 2016 | 46.19M |
| March 31, 2016 | 55.94M |
| December 31, 2015 | 64.51M |
| September 30, 2015 | 75.99M |
| June 30, 2015 | 80.58M |
| March 31, 2015 | 87.62M |
| December 31, 2014 | 29.78M |
| September 30, 2014 | 34.65M |
| June 30, 2014 | 39.41M |
| March 31, 2014 | 40.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.97M |
| Total Liabilities (Quarterly) | 14.28M |
| Debt to Equity Ratio | 0.2224 |
| Current Ratio | 0.4917 |
| Net Debt Paydown Yield | 32.73% |